ReviewProbiotics and antimicrobial proteins2026
Potential Role of Prebiotics and Probiotics on Oocyte Quality, Embryo Development, Endometrial Health, and Fertility Outcomes in Assisted Reproductive Technologies.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assisted reproductive technologies (ART) have transformed infertility treatment over recent decades, yet success rates remain inconsistent. Beyond the established embryological and hormonal determinants, emerging research identifies the human microbiome-particularly gut and reproductive tract communities-as a critical regulator of reproductive efficiency. The gut microbiota influences endocrine balance, metabolic signaling, and immune homeostasis, all of which have a direct impact on oocyte maturation, embryo viability, and endometrial receptivity. Dysbiosis, characterized by the depletion of beneficial lactobacilli and an increase in pro-inflammatory bacterial taxa, has been associated with oxidative stress, reduced oocyte competence, and implantation failure. In contrast, a balanced microbiota supports follicular health and hormonal coordination. Prebiotic and probiotic interventions may enhance reproductive outcomes through several complementary mechanisms. By restoring a Lactobacillus-dominant microbial profile, they help stabilize the reproductive tract ecosystem, reinforce epithelial and immune barrier function, and limit the overgrowth of potentially pathogenic species. These changes reduce local inflammation and oxidative stress while promoting the secretion of antimicrobial peptides and bacteriocins that maintain tissue integrity. Collectively, these microbiome-mediated effects can contribute to improved follicular fluid homeostasis, enhanced oocyte competence, better early embryo development, and ultimately higher ART success rates. In conclusion, modulation of the gut-reproductive axis through targeted probiotic or prebiotic therapy represents a promising biological adjunct to assisted reproduction. Further mechanistic studies and large-scale randomized trials are warranted to validate its clinical applicability and optimize therapeutic regimens.
Indexed as
Identifiers
42606639What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.